- Termination of Registration of a Class of Security under Section 12(g) (15-12G)
17 Abril 2009 - 4:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE
OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 0-21643
Gilead Palo Alto, Inc. (formerly CV
Therapeutics, Inc.)
(Exact name of registrant as specified in its charter)
3172 Porter Drive
Palo Alto, CA
94304
(650) 384-8500
(Address, including zip code, and telephone
number,
including area code, of registrants principal executive offices)
Common Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)
N/A
(Titles of all other classes of securities for which a duty to file
reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file
reports:
|
|
|
Rule 12g-4(a)(1)
|
|
x
|
Rule 12g-4(a)(2)
|
|
¨
|
Rule 12h-3(b)(1)(i)
|
|
x
|
Rule 12h-3(b)(1)(ii)
|
|
¨
|
Rule 15d-6
|
|
¨
|
Approximate number of holders of record as of the certification or notice date:
One
Pursuant to the requirements of
the Securities Exchange Act of 1934, Gilead Palo Alto, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
Date: April 17, 2009
|
|
|
|
By:
|
|
/
S
/ G
REGG
H. A
LTON
|
|
|
|
|
|
|
Gregg H. Alton
|
|
|
|
|
|
|
Secretary
|
CV Therapeutics (NASDAQ:CVTX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
CV Therapeutics (NASDAQ:CVTX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about CV Therapeutics (MM) (NASDAQ): 0 recent articles
Más de Artículos de Noticias